Ardea Biosciences, Inc. (RDEA) Reports Q3 Loss of $0.84, Sales Miss Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq set for lower open as AI stocks slide on debt concerns
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent oil slips as US weighs easing sanctions on Russia's 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts RDEA Hot Sheet
Price: $31.96 --0%
Financial Fact:
Total other income (expense): 91K
Today's EPS Names:
NTRP, FMCB, LOOP, More
Financial Fact:
Total other income (expense): 91K
Today's EPS Names:
NTRP, FMCB, LOOP, More
Join SI Premium – FREE
Ardea Biosciences, Inc. (NASDAQ: RDEA) reported Q3 EPS of ($0.84), $0.17 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.95 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ManpowerGroup (MAN) Reports In-Line Q3 EPS; offers guidance
- PNC Financial Services (PNC) Tops Q3 EPS by 18c
- AZZ, Inc. (AZZ) Tops Q2 EPS by 15c; raises guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
